79 related articles for article (PubMed ID: 8334332)
1. [Treatment of age-associated macular degeneration with interferon-alfa-2a].
Thölen A; Kain H; Messmer E
Ophthalmologe; 1993 Jun; 90(3):279-82. PubMed ID: 8334332
[TBL] [Abstract][Full Text] [Related]
2. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
[TBL] [Abstract][Full Text] [Related]
3. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
Thoelen A; Menozzi M; Huber C; Messmer E
Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
Jaakkola A; Anttila PM; Immonen I
Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
[TBL] [Abstract][Full Text] [Related]
7. [Feeder vessel treatment of choroidal neovascularization in age-related macular degeneration].
Coscas F; Stanescu D; Coscas G; Soubrane G
J Fr Ophtalmol; 2003 Jun; 26(6):602-8. PubMed ID: 12910200
[TBL] [Abstract][Full Text] [Related]
8. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration.
Kaiser PK; Blodi BA; Shapiro H; Acharya NR;
Ophthalmology; 2007 Oct; 114(10):1868-75. PubMed ID: 17628683
[TBL] [Abstract][Full Text] [Related]
9. Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Avila MP; Farah ME; Santos A; Carla L; Fuji G; Rossi J; Nau J
Retina; 2012 Jan; 32(1):10-8. PubMed ID: 21817963
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
Kirkpatrick JN; Dick AD; Forrester JV
Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
[TBL] [Abstract][Full Text] [Related]
11. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
[TBL] [Abstract][Full Text] [Related]
12. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.
Cho HJ; Kim CG; Yoo SJ; Cho SW; Lee DW; Kim JW; Lee JH
Am J Ophthalmol; 2013 Jan; 155(1):118-126.e1. PubMed ID: 23022163
[TBL] [Abstract][Full Text] [Related]
13. Transpupillary thermotherapy for occult subfoveal neovessels in age-related macular degeneration: importance of patient pigmentation for the determination of laser settings.
Auer C; Tao Tran V; Herbort CP
Klin Monbl Augenheilkd; 2002 Apr; 219(4):250-3. PubMed ID: 12022011
[TBL] [Abstract][Full Text] [Related]
14. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.
Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH
Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab for exudative age-related macular degeneration: effect on different subfoveal membranes.
Tao Y; Jonas JB
Retina; 2010 Oct; 30(9):1426-31. PubMed ID: 20539255
[TBL] [Abstract][Full Text] [Related]
16. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation.
Bottoni F; Massacesi A; Cigada M; Viola F; Musicco I; Staurenghi G
Arch Ophthalmol; 2005 Dec; 123(12):1644-50. PubMed ID: 16344434
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of exudative age-related macular degeneration].
Yuzawa M
Nippon Ganka Gakkai Zasshi; 2000 Dec; 104(12):875-98. PubMed ID: 11193943
[TBL] [Abstract][Full Text] [Related]
18. The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study.
Kertes PJ; Coupland SG
Can J Ophthalmol; 2005 Oct; 40(5):573-84. PubMed ID: 16391620
[TBL] [Abstract][Full Text] [Related]
19. Transpupillary thermotherapy in subfoveal choroidal neovascular membrane secondary to age-related macular degeneration.
Verma L; Tewari HK; Nainiwal S; Ravindranathan J
Indian J Ophthalmol; 2004 Mar; 52(1):35-40. PubMed ID: 15132377
[TBL] [Abstract][Full Text] [Related]
20. [Results of perifoveal argon laser coagulation of subfoveal choroid neovascularization in age related macular degeneration].
Spraul CW; Lang GE; Lang GK
Ophthalmologe; 1995 Oct; 92(5):640-6. PubMed ID: 8750988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
